Clinical trial
Impact of Resveratrol and Pharmaceutical Care on Diabetes Mellitus and Its Neuropathic Complication
NCT05172947 is registered in ClinicalTrials.gov with University of Sulaimani as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Resveratrol and Pharmaceutical Care on Diabetes Mellitus and Its Neuropathic Complication
- Lead sponsor
- University of Sulaimani
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 5, 2021
- Completion date
- December 15, 2022
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.